Xenoport's psoriasis drug had mixed results in Phase 2, but it's oral. The FUD over there is that there's no BP interested in P. Well, if Dr. Reddy's willing to sign a $490M licensing deal, I have no doubt that Leo can get us a better deal.

Under pressure, XenoPort sells U.S. rights of failed psoriasis pill to Dr. Reddy's

http://www.fiercebiotech.com/r-d/under-pressu...dr-reddy-s

Quote:

---

Good catch. Actually that makes me wonder if Dr. Reddy's is NOT the one because they are invested in this other drug. Of course if that other drug doesn't work, then wowee yes I bet they'd want to have Prurisol.

---